Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Accounts Payables: 2020-2022

Historic Accounts Payables for Candel Therapeutics (CADL) over the last 3 years, with Dec 2022 value amounting to $380,000.

  • Candel Therapeutics' Accounts Payables fell 74.23% to $250,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $250,000, marking a year-over-year decrease of 74.23%. This contributed to the annual value of $380,000 for FY2022, which is 76.10% down from last year.
  • Per Candel Therapeutics' latest filing, its Accounts Payables stood at $380,000 for FY2022, which was down 76.10% from $1.6 million recorded in FY2021.
  • In the past 5 years, Candel Therapeutics' Accounts Payables registered a high of $1.6 million during FY2021, and its lowest value of $380,000 during FY2022.
  • Moreover, its 3-year median value for Accounts Payables was $921,000 (2020), whereas its average is $963,667.
  • As far as peak fluctuations go, Candel Therapeutics' Accounts Payables skyrocketed by 72.64% in 2021, and later slumped by 76.10% in 2022.
  • Candel Therapeutics' Accounts Payables (Yearly) stood at $921,000 in 2020, then soared by 72.64% to $1.6 million in 2021, then slumped by 76.10% to $380,000 in 2022.